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Research
There is now a large body of evidence 
  documenting the adverse effects of secondhand 
smoke (SHS, also called environmental tobacco 
smoke) exposure among nonsmoking adults. 
These effects mirror those associated with 
active smoking, with SHS exposure now caus­
ally linked with coronary heart disease, lung 
and nasal sinus cancer and associated with an 
increased risk of other cancers, stroke, chronic 
respiratory symptoms and adverse pregnancy 
outcomes (California Environmental Protection 
Agency 2005). Although most reported relative 
risks are generally low, large numbers of non­
smokers are at risk because exposure has histori­
cally been ubiquitous, occurring in the home, 
at work, in enclosed public places and other 
social settings, and the population harm arising 
from exposure to SHS is therefore significant. 
Measures to reduce exposure to SHS, including 
legislation prohibiting smoking in public and 
work places, are therefore expected to result in 
health benefits (U.S. Department of Health 
and Human Services 2006).
Comprehensive smoking bans have now 
been implemented in several jurisdictions 
worldwide. Evaluations of the legislation docu­
ment substantial improvements in air quality 
in public venues and reductions in SHS 
exposure and related respiratory and sensory 
symptoms in hospitality workers and patrons 
[International Agency for Research on Cancer 
(IARC) 2009]. Evidence of health benefits, 
most notably reductions in hospital admissions 
for coronary events, in the general population 
is also accumulating (Barone­Adesi et al. 2011; 
Juster et al. 2007; Naiman et al. 2010; Sims 
et al. 2010a). Such evaluations presuppose 
that legislation reduces SHS exposure among 
the general population, yet only a few studies, 
one in Scotland and two in the United 
States, have yet examined this using a specific 
biomarker of tobacco smoke exposure (Adda 
and Cornaglia 2010; Bauer et al. 2007; Haw 
and Gruer 2007). The two that examined 
implementation of specific legislation found 
significant reductions in exposure among 
nonsmoking adults, although neither was able 
to account for underlying secular declines in 
exposure (Bauer et al. 2007; Haw and Gruer 
2007). The third was conducted by Adda and 
Cornaglia (2010) who used regression models 
to examine whether cotinine levels varied with 
the extent of smokefree legis  lation in U.S. 
states; they found no signifi  cant impact among 
nonsmoking adults. That study, however, has 
been critiqued because the investigators were 
unable to fully account for whether individuals 
lived in municipalities or counties that were 
smokefree (IARC 2009).
In this study, we aimed to determine 
whether the introduction of smokefree leg­
islation in England on 1 July 2007 led to 
changes in SHS exposure among nonsmoking 
adults (Department of Health 2008). Such 
exposure has been found, both in the United 
States and in England, to vary by the extent 
of smoking in the home and socioeconomic 
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Ba c k g r o u n d: On 1 July 2007, smokefree legislation was implemented in England, which made 
virtually all enclosed public places and workplaces smokefree.
oBjectives: We examined trends in and predictors of secondhand smoke exposure among non­
smoking adults to determine whether exposure changed after the introduction of smokefree legislation 
and whether these changes varied by socioeconomic status (SES) and by household smoking status.
Me t h o d s : We analyzed salivary cotinine data from the Health Survey for England that were col­
lected in 7 of 11 annual surveys undertaken between 1998 and 2008. We conducted multivariate 
regression analyses to examine secondhand smoke exposure as measured by the proportion of non­
smokers with undetectable levels of cotinine and by geometric mean cotinine.
re s u l t s: Secondhand smoke exposure was higher among those exposed at home and among lower­
SES groups. Exposure declined markedly from 1998 to 2008 (the proportion of participants with 
undetectable cotinine was 2.9 times higher in the last 6 months of 2008 compared with the first 
6 months of 1998 and geometric mean cotinine declined by 80%). We observed a significant fall in 
exposure after legislation was introduced—the odds of having undetectable cotinine were 1.5 times 
higher [95% confidence interval (CI): 1.3, 1.8] and geometric mean cotinine fell by 27% (95% CI: 
17%, 36%) after adjusting for the prelegislative trend and potential confounders. Significant reduc­
tions were not, however, seen in those living in lower­social class households or homes where smok­
ing occurs inside on most days.
co n c l u s i o n s: We found that the impact of England’s smokefree legislation on secondhand smoke 
exposure was above and beyond the underlying long­term decline in secondhand smoke exposure 
and demonstrates the positive effect of the legislation. Nevertheless, some population subgroups 
appear not to have benefitted significantly from the legislation. This finding suggests that these 
groups should receive more support to reduce their exposure.
key w o r d s : cotinine, environmental tobacco smoke, evaluation, nonsmokers, passive smoke, 
secondhand smoke, smokefree legislation, smoking ban. Environ Health Perspect 120:425–430 
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status (SES) (Jarvis et al. 2001; Pirkle et al. 
2006; Royal College of Physicians 2005). 
Therefore, we explored whether these inequal­
ities in exposure changed after legislation was 
introduced. In addition, we report on the 
trend in SHS exposure among the general 
population in England from 1998 to 2008, 
updating an earlier study (Royal College of 
Physicians 2005). Finally, because previous 
analyses in England have focused only on 
nonsmoking adults living with a partner who 
smokes (Jarvis et al. 2001) and on children 
(Sims et al. 2010b), we explored other factors 
related to SHS   exposure in detail.
Methods
Data. We obtained 11 years of data (1998 
to 2008 inclusive) from the Health Survey 
for England, an annual, representative, cross­
sectional survey of individuals living in private 
households in England (Department of Health 
2010; NHS Information Centre 2010a). The 
survey design ensures that the population 
sampled in each quarter of the year is nation­
ally representative. Data collection involves an 
interviewer visit, in which all adults ≥ 16 years 
of age and up to two children in each house­
hold are eligible to be interviewed, followed by 
a nurse visit. In 7 of 11 annual surveys under­
taken between 1998 and 2008 [specifically 
1998, 2000 (second half of 2000 only—1 July 
to 31 December), 2001–2003, 2007 and 
2008], the nurse collected saliva samples from 
adults to measure cotinine, a metabolite of 
nicotine that is considered a reliable marker of 
tobacco smoke exposure in the previous 72 hr 
(Benowitz 1996). Salivary cotinine levels were 
measured using a gas chromatographic method 
with a lower limit of detection of 0.1 ng/ml 
(Feyerabend and Russell 1990). In 2008, the 
methodology was changed to a liquid chroma­
tography tandem mass spectrometry method 
(LC­MS/MS; Bernert et al. 2009). These two 
methods produced comparable results for the 
determination of cotinine (Bernert et al. 2009; 
Craig et al. 2009). Cotinine levels below this 
limit are classed as undetectable. We based 
our analyses on nonsmoking adults, defined 
as those who self­reported that they did not 
currently smoke a cigarette, pipe, or cigar and 
who had a salivary cotinine concentration of 
< 12 ng/ml (now considered the most accu­
rate cut off for active smoking among adults) 
(Jarvis et al. 2008).
Survey design and outcome measures. 
We analyzed the data using regression mod­
els, with adjustments for the complex survey 
design involving clustering and stratification; 
the analyses were performed using the survey 
package in R (version 2.9.0; The R Foundation 
for Statisitical Computing, Vienna, Austria). 
We used weights provided by the Health 
Survey for England (Craig et al. 2009) to 
compensate for any nonresponse to the nurse 
visit. These weights are available from 2003 
to 2008. In the 2007 survey, an additional 
weight was introduced to further adjust for 
nonparticipation in the saliva sample, and we 
used this weight when it became available.
Two outcome measures were considered: 
undetectable cotinine (a binary outcome meas­
ure with a value of 1 for those with cotinine 
below the lower detection limit and 0 for those 
above the detection limit) and log­transformed 
cotinine. For the latter, adults with cotinine 
concentrations below the lower detection limit 
were assigned a value using regression on order 
statistics, an imputation method that assigns 
values to nondetect data based on a probability 
plot of the detected data (Helsel 2010; Hewett 
and Ganser 2007). The methods detailed 
below describe the logistic regression models 
applied to the binary outcome (undetectable 
cotinine). These methods were repeated using 
regression models with normally distributed 
errors, using the log­transformed cotinine out­
come, to model geometric mean cotinine. The 
geometric mean is considered to be a better 
summary measure of average cotinine given 
the skewed distribution of the raw cotinine 
data. Results in the main text are rounded 
to two significant figures. All tests were two­
sided, and statistical significance was defined 
as p < 0.05.
Predictors of secondhand smoke exposure.
Univariate regression. Univariate logistic 
regression analysis was used to examine the 
relationships between sociodemographic pre­
dictors of exposure to SHS and the propor­
tion of nonsmoking adults with undetectable 
cotinine. Sociodemographic data included age, 
sex, ethnicity, education of the respondent, 
social class of the head of household (meas­
ured using the British Registrar General’s clas­
sification (Office of Population Censuses and 
Surveys 1991), and whether there was smok­
ing in the home on most days. Smoking in the 
home was based on the response of the head 
of household to the question, “Does anyone 
smoke inside this house/flat on most days?”
Multivariate regression. Multivariate logis­
tic regression was used to estimate the effect 
of each predictor on the proportion of non­
smoking adults with undetectable cotinine after 
adjusting for other predictor variables, includ­
ing long­term trends. To evaluate changes over 
time, we created a “time” variable (to identify 
the 6­month period during which saliva sam­
ples that were used to determine cotinine levels 
were collected (6­month periods numbered 
consecutively from 1, for those with a nurse 
visit from 1 January to 30 June in the 1998 
survey, to 22, for those with a nurse visit from 
1 July to 31 December in the 2008 survey). 
Given the periods of missing cotinine data, 
quantifying the long­term trend in SHS expo­
sure was difficult. We considered linear, qua­
dratic, and cubic terms for the time variable to 
model the trend. The cubic term was not sig­
nificant (p > 0.05), but the others were; there­
fore, we included both linear and quadratic 
terms in order to model the trend.
Impacts of legislation. Overall impact of 
the smokefree legislation. We examined the 
impact of smokefree legislation in two ways. 
First, we included a binary predictor vari­
able in the multivariate model with a value 
of 1 assigned to adults who had their saliva 
sample collected after 1 July 2007 and a value 
of 0 before this date. This model indicated 
whether there had been an immediate change 
in the proportion of nonsmoking adults with 
undetectable cotinine after adjusting for the 
long­term trend (modeled using both linear 
and quadratic terms for time) and temporal 
variation in sociodemographic circumstances.
Second, to avoid making an assumption 
about the nature of the trend in exposure, we 
compared the odds of having undetectable 
cotinine in each 6­month period (as defined 
by the time variable) with that in the previous 
6­month period to assess whether there was 
a significant increase in the odds of having 
  undetectable cotinine from the first to second 
half of 2007 and whether the increase was 
greater than the other 6­month comparisons. 
Odds and odds ratios (ORs) were calculated 
using the multivariate logistic regression model, 
but without the smokefree legislation predictor 
and with the linear and quadratic terms for 
time variable replaced by 12 dummy variables, 
coded in a way that enables a comparison 
between one 6­month period and the preceding 
one [see Supplemental Material, pages 2–6 
(http://dx.doi.org/10.1289/ehp.1103680)].
Variation in impacts of the smokefree 
legis  lation by household smoking status and 
social class. To assess whether the impacts 
of smokefree legislation varied by household 
smoking status, we used a multivariate model, 
as described above, with the addition of two 
interaction terms. The first, between house­
hold smoking status and the binary indicator 
of smokefree legislation, assessed whether any 
change following the introduction of smoke­
free legislation varied by the household smok­
ing status. The second, between the household 
smoking status predictor and the linear and 
quadratic terms for the time variable, adjusts 
for differences in the long­term trend among 
these subgroups. This approach was repeated 
to explore impacts by social class but with 
household smoking status replaced by social 
class in the interaction terms.
To validate these findings (and again to 
avoid making assumptions about the nature 
of the trend) we applied the logistic regression 
model in which the odds of having undetectable 
cotinine in each 6­month period were com­
pared with the odds in the previous 6­month 
period for each subgroup of adults defined by 
household smoking status and social class.Impact of smokefree legislation in England
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Results
Determinants of secondhand smoke exposure. 
Using undetectable cotinine as the outcome, 
all predictors were significantly associated with 
secondhand smoke exposure, except ethnicity 
(black or Asian vs. white), both in the univari­
ate and multivariate models (Table 1). Having 
controlled for the other predictors, the odds of 
having undetectable cotinine increased with 
age (1.6, 1.8, and 2.2 times that of people 
16–29 years of age for those in the 30–44­, 
45–59­, and ≥ 60­year age groups, respec­
tively) and decreased with declining SES status 
with the lowest levels in social class IV and 
V [29% lower than social class I and II, 95% 
confidence interval (CI): 21, 35] and in adults 
with no qualifications (19% lower than those 
with a higher education qualification, 95% 
CI: 11, 26). The odds of having undetectable 
cotinine were 1.2 times higher among women 
than among men (95% CI: 1.2, 1.3) and 8.1 
times higher among adults living in house­
holds where someone did not smoke inside 
on most days compared with households 
where someone did (95% CI: 6.6, 10). 
Similar patterns also were observed when all 
the predictors were examined in relation to 
geometric mean cotinine [see Supplemental 
Material, Table 1 (http://dx.doi.org/10.1289/
ehp.1103680)].
Impact of legislation. Overall impact 
of the smokefree legislation. The percent­
age of nonsmokers with undetectable coti­
nine increased considerably over time from 
19% (95% CI: 17%, 20%) in the first half 
of 1998 to 54% (95% CI: 52%, 56%) in the 
second half of 2008 with a clear increase seen 
between the first and second 6­month peri­
ods of 2007 (Figure 1A). Similarly, geomet­
ric mean cotinine declined from 0.36 ng/ml 
(95% CI: 0.34, 0.39) in the first half of 1998 
to 0.071 ng/ml (95% CI: 0.066, 0.077) in 
the second half of 2008 (Figure 1B).
Assuming a quadratic prelegislative trend 
in the log odds of exposure and adjusting for 
the sociodemiographic predictors, the odds of 
having undetectable cotinine were 1.5 (95% 
CI: 1.3, 1.8) times higher after the smokefree 
legislation was introduced than before it was 
introduced (Table 1).
Evidence of a significant impact of the 
legislation was further supported by our sec­
ond analysis that showed the OR for unde­
tectable cotinine between the second and first 
halves of 2007 (postlegislation vs. prelegis­
lation) was 1.8 (95% CI: 1.5, 2.2), signifi­
cantly higher than that for all other 6­month 
comparisons in the 9 years preceding legis­
lation (their ORs ranged from 0.88 to 1.3; 
p < 0.05 in all comparisons), with the excep­
tion of the OR comparing the second and 
first half of 2001 (OR = 1.5, p = .08) [see 
Supplemental Material, Figure 1 (http://
dx.doi.org/10.1289/ehp.1103680)].
Significant reductions in exposure follow­
ing smokefree legislation also were observed 
using both analyses when geometric mean 
cotinine was used as the outcome variable, 
with the first analysis identifying a 27% 
(95% CI: 17%, 36%) fall in geometric mean 
cotinine [see Supplemental Material, Table 1 
(http://dx.doi.org/10.1289/ehp.1103680)] 
Table 1. Factors associated with undetectable cotinine levels in nonsmoking adults and impacts of smokefree legislation, Health Survey for England, 1998–2008.
Sample 
(n)
Percent with 
undetectable 
cotinine
Unadjusted OR,a 
univariate regression
Adjusted OR,a 
multivariate regressionb
Predictor variable Levels in predictor variable Estimate (95% CI) Estimate (95% CI)
Smokefree legislation Before 1 July 2007 —
After 1 July 2007 1.52 (1.29, 1.79)**
Age (years) 16–29 4,352 20.7 — —
30–44 8,087 27.7 1.47 (1.33, 1.62)** 1.56 (1.41, 1.73)**
45–59 8,031 29.2 1.58 (1.44, 1.75)** 1.76 (1.59, 1.95)**
≥ 60 9,815 33.5 1.93 (1.75, 2.13)** 2.21 (1.99, 2.46)**
Sex Male 13,570 27.1 — —
Female 16,715 30.0 1.15 (1.10, 1.21)** 1.23 (1.17, 1.30)**
Social class of head of household I and II (professional, managerial, and technical) 13,546 32.9 — —
III (skilled nonmanual and manual) 11,333 26.1 0.72 (0.68, 0.77)** 0.81 (0.76, 0.87)**
IV and V (semiskilled and unskilled manual) 4,719 23.3 0.62 (0.57, 0.68)** 0.71 (0.65, 0.79)**
Education level of individual Higher education qualification 9,518 32.6 — —
School level (or other) qualifications 13,183 26.9 0.76 (0.72, 0.81)** 0.92 (0.86, 0.98)*
No qualification 7,570 27.0 0.77 (0.71, 0.82)** 0.81 (0.74, 0.89)**
Ethnicity Whitec 28,225 28.7 — —
Black or Asian 1,638 28.7 1.00 (0.88, 1.15) 0.94 (0.81, 1.09)
Someone smokes most days 
inside the home?
Yesc 2,858 4.4 — —
No 27,420 31.3 9.90 (8.09, 12.1)** 8.11 (6.57, 10.0)**
—, indicates baseline category. 
aCompares the ratio of the odds between a category and the baseline category. These estimates were derived by exponentiating the regression coefficients from the regression model. 
Regression results rounded to two decimal places.bModel includes a linear and quadratic term for time. cIncludes qualifications obtained outside the United Kingdom, Nursery Nurse 
Examination Board, and Clerical and Commercial qualification. *p < 0.05 and **p < 0.01 indicates a significant difference from the baseline category.
Figure 1. Trends in SHS exposure in nonsmoking adults in England from 1998 to 2008 in 6-month time periods using the proportion with undetectable cotinine (A), and 
geometric mean cotinine (B). Error bars indicate 95% CIs. SFL (smokefree legislation) shows the date when legislation was implemented.
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and the second analysis showing that the per­
centage fall, derived from the ratio of geo­
metric mean cotinine, between the second 
half (1 July through 31 December) and the 
first half (1 January through 30 June) of 
2007 (postlegislation vs. prelegislation) was 
38% (95% CI: 28%, 46%), significantly 
greater than all other 6­month comparisons 
in the 9 years preceding legislation (percent­
age change ranged from a fall of 13% to an 
increase of 118%; p < 0.05 in all compari­
sons) [see Supplemental Material, Figure 1 
(http://dx.doi.org/10.1289/ehp.1103680)].
Variation in the estimated impact of the 
smokefree legislation by household smoking 
status and social class. The impacts of legisla­
tion appeared to vary by population subgroup 
(Table 2, Figure 2A–D). Significant impacts 
were observed only among those living in 
homes where there was no smoking inside on 
most days and among those from social classes 
I to III. For those living in homes where there 
was no smoking inside on most days, the 
odds of having undetectable cotinine were 
1.6 (95% CI: 1.3, 1.9) times higher after the 
legislation was implemented and geometric 
mean cotinine fell by 31% (95% CI: 21%, 
39%) after adjusting for underlying trends 
and potential confounders. The odds of hav­
ing undetectable cotinine were 1.8 (95% CI: 
1.4, 2.3) times higher among those in social 
classes I and II and 1.5 (95% CI: 1.1, 1.9) 
times higher among those in social classes III 
after the legislation, whereas geometric mean 
cotinine levels fell by 37% (95% CI: 24%, 
48%) and 23% (95% CI: 6%, 37%) respec­
tively. By contrast, no significant impact was 
seen in adults living in households where 
someone smoked inside on most days or in 
social classes IV and V when measured using 
either the OR of undetectable cotinine [0.38 
(95% CI: 0.12, 1.2) and 1.00 (95% CI: 0.64, 
1.6) respectively], or multiplicative change in 
geometric cotinine [1.5 (95% CI: 0.89, 2.5) 
and 1.0 (95% CI: 0.7, 1.4) respectively].
These patterns were largely confirmed in 
the second analysis comparing the odds across 
6­month periods. For those living in homes 
where there was smoking inside on most days 
and from social classes III, IV, and V, there 
was no evidence that the OR of undetect­
able cotinine or the decrease in geometric 
mean cotinine between the first and second 
halves of 2007 were significantly greater than 
in other 6­month comparisons in the 9 years 
preceding legislation. By contrast, for those 
living in homes with no smoking inside the 
home or for those in social classes I and II, 
the OR of undetectable cotinine between 
the first half and the second half of 2007, 
Table 2. Estimated impacts (95% CI) of smokefree legislation on SHS exposure among nonsmoking adults by social class and by whether smoking occurred 
inside the home on most days.
Predictor variablea Levels in predictor variable
OR for 
undetectable cotinineb
Multiplicative change in 
geometric mean cotininec
Social class (head of household) I and II (professional, managerial and technical) 1.76 (1.38, 2.25)* 0.63 (0.52, 0.76)*
III (skilled nonmanual and manual) 1.48 (1.14, 1.92)* 0.77 (0.63, 0.94)*
IV and V (semi-skilled and unskilled manual) 1.00 (0.64, 1.56)# 1.01 (0.70, 1.44)#
Someone smokes most days inside the home? Yes 0.38 (0.12, 1.16) 1.48 (0.89, 2.47)
No 1.58 (1.34, 1.86)*# 0.69 (0.61, 0.79)*#
aResults for social class based on multivariate models with predictors (i.e. smokefree legislation, age, sex, social class, education, ethnicity, whether someone smokes most days 
inside the home, and a linear and quadratic term for time) and two interactions—the first between social class and the linear and quadratic terms for time and the second between 
social class and the binary indicator of smokefree legislation. Results for household smoking status are based on the same models but with household smoking status replacing social 
class in the interaction terms. Results rounded to two decimal places. bRatio in odds of undetectable cotinine after the legislation was introduced on 1 July 2007 compared with before 
it was introduced, derived from the smokefree legislation predictor and its interaction term. cRatio of geometric mean cotinine after the legislation was introduced on 1 July 2007 com-
pared with before its introduction, derived from the smokefree legislation predictor and its interaction term. *Significantly different (p < 0.05) from 1 (no change). #Significantly different 
(p < 0.05) from baseline category (either social class I and II or answering “yes” to whether someone smoked most days inside the home).
Figure 2. Trends in SHS exposure among nonsmoking adults in England from 1998 to 2008 in 6-month time periods by household smoking status (A and B) and 
social class of head of household (C and D) using proportion with undetectable cotinine (A and C), geometric mean cotinine (B and D). Error bars indicate 95% CIs. 
SFL (smokefree legislation) indicates when the legislation was implemented.
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1.9 (95% CI: 1.6, 2.2) and 2.0 (95% CI: 1.6, 
2.6) respectively, were significantly higher 
than were those for all 6­month comparisons 
in the 9 years preceding legislation (range, 
0.84–1.3 and 0.78–1.2 respectively; p < 0.05 
in all comparisons) with the exception of the 
OR between the first half and the second half 
of 2001 (1.5 and 1.6 respectively, p > 0.05). 
For those living in homes with no smoking 
inside or for those in social classes I and II, 
the percentage fall in geometric mean cotinine 
between the first and the second half of 2007 
was 39% (95% CI: 30%, 47%) and 44% 
(95% CI: 32%, 54%), respectively; these per­
centages were significantly greater than all 
6­month comparisons in the 9 years preced­
ing legislation (percentage change ranged 
from a fall of 14% to a rise of 118% and a fall 
of 13% to rise of 117%, respectively; p < 0.05 
in all comparisons; data not shown).
Discussion
Levels of SHS exposure among nonsmoking 
adults declined significantly after smokefree 
legislation was introduced in England. After 
adjusting for prelegislative trends and other fac­
tors that may influence exposure, we found that 
the odds of having undetectable cotinine were 
1.5 times higher after the legislation and that 
geometric mean cotinine levels fell by 27%. 
This reduction in SHS exposure among non­
smoking adults is consistent with that observed 
after the introduction of smoking bans in New 
York (Bauer et al. 2007) and Scotland (Haw 
and Gruer 2007) (geometric mean saliva coti­
nine levels declining by 47% and 39% respec­
tively). The smaller estimated impact observed 
in England may be partly explained by our 
adjustment for the prelegislative trend, an issue 
not considered in the other studies, and by the 
lower levels of prelegislative exposure [certainly 
compared with Scotland where the geometric 
mean cotinine concentration for the 7­month 
period preceding their smokefree legislation 
was 0.43 ng/ml (Haw and Gruer 2007) com­
pared with 0.14 ng/ml in our study].
The major strength of this study is that it 
was based on a large and representative survey 
of the general population using cotinine as a 
biomarker of SHS exposure. Although coti­
nine is a metabolite of nicotine, and it is not 
the nicotine itself that causes harm, studies 
have shown that cotinine concentrations cor­
relate with those of carcinogenic compounds 
in cigarette smoke (Hecht et al. 2001) and 
are associated with elevated risks of cardio­
vascular and respiratory disease (Chan­Yeung 
and Dimich­Ward 2003; Whincup et al. 
2004). Our study is one of only a few that has 
examined the impact of smokefree legislation 
on population level exposure to secondhand 
smoke, and it has advantages over other stud­
ies both in using a variety of outcome mea­
sures and methods and in taking into account 
the underlying downward trend in exposure 
observed between 1998 and 2008.
The main weakness of this study is the 
absence of cotinine data from 2004 to 2006 
and the resulting difficulty of specifying the 
trend in exposure during this period. Incorrect 
trend specification might bias the estimated 
impact of smokefree legislation. However, 
we considered a number of trend options 
and, using the data available, we judged the 
quadratic trend to be the most appropriate. 
Furthermore, to avoid making any assumption 
about trend (and thus to overcome this prob­
lem) we performed a supplementary analysis 
in which the magnitude of the change between 
the 6 months before the legislation being 
implemented and the 6 months postlegislation 
was compared with that change observed in 
any other 6­month comparison, and our con­
clusions were the same. A further limitation is 
the effect that the timing of the saliva sample 
collection might have had on cotinine levels 
given evidence that cotinine levels are lower 
in the morning than in the evening (Jarvis 
et al. 1984). In the Health Survey for England, 
nurse visits were relatively more common after 
1700 hours for those in professional and man­
agerial households (Mindell et al. 2011). Thus 
differences in cotinine levels between profes­
sional and managerial households compared 
with lower­SES households may be attribut­
able in part to the timing of the saliva sample 
collection. However, if the bias is consistent 
over time, it cannot account for the differences 
in trend between these groups. Finally, it is 
important not to interpret the reported OR as 
prevalence rate ratios, because ORs will always 
be further away from 1 (the null value) than 
will prevalence rate ratios (except when the lat­
ter is equal to 1), and the discrepancy is more 
pronounced when the outcome is relatively 
common, as is the proportion with undetect­
able cotinine (Zocchetti et al.1997).
This study also documents marked declines 
in SHS exposure among nonsmoking adults 
between 1998 and 2008 (the proportion with 
undetectable cotinine was 2.9 times higher 
and geometric mean cotinine fell by 80%). 
This is in line with the decline of 59% in geo­
metric mean cotinine observed in children 
over a similar period (1996–2006) (Sims et al. 
2010b). Such trends likely reflect the strength­
ening of tobacco control strategies during this 
period resulting in declining smoking rates 
[from 27% in 1998 (Department of Health 
2000) to 21% in 2008 (NHS Information 
Centre 2010b)], changing knowledge (Evans 
2010) and a growth in voluntary home­smok­
ing restrictions (Jarvis et al. 2009) as well as 
increasing restrictions on smoking in public 
places implemented in advance of the legisla­
tion. Salivary cotinine concentrations declined 
both among those living in homes where no 
smoking occurs inside, from a geometric mean 
of 0.29 (95% CI: 0.27, 0.31) in the first 6 
months of 1998 to 0.062 (95% CI: 0.058, 
0.067) in the last 6 months of 2008 and 
among those living in homes in which smok­
ing occurs inside on most days, from a geo­
metric mean of 1.4 (95% CI: 1.2, 1.6) in the 
first 6 months of 1998 to 0.60 (95% CI: 0.47, 
0.77) in the last 6 months of 2008. While 
the former must reflect changes in exposure 
outside the home, the latter could reflect 
reductions in exposure both outside and inside 
the home (if those smoking inside the home 
reduced their consumption or made attempts 
to smoke elsewhere). Nevertheless, salivary 
cotinine concentrations remained much higher 
among adults exposed at home and somewhat 
higher among lower­SES groups (Figure 2).
Living in a home where smoking is 
allowed was identified as an important deter­
minant of exposure. Other factors were also 
important and remained so even after control­
ling for household smoking status. Consistent 
with other studies (Ellis et al. 2009; Jarvis 
et al. 2001; Pirkle et al. 2006), our findings 
showed that men and persons in the youngest 
age groups were most exposed, as were those 
from lower­SES groups.
Although the impact of legislation on 
exposure among nonsmokers varied by house­
hold smoking status and social class, there was 
no significant difference by age group (results 
not shown). It is noteworthy that smokefree 
legislation had little impact upon those who 
are most exposed to SHS: nonsmokers living 
in households where smoking occurs inside on 
most days and those from lower social classes. 
A similar pattern, of a significant reduction 
in exposure among nonsmoking adults from 
nonsmoking but not smoking households, 
was observed in Scotland (Haw and Gruer 
2007), although another study reported that 
smoking bans in the United States had no 
effect on exposure among nonsmoking adults 
regardless of household smoking status (Adda 
and Cornaglia 2010). It is likely that for non­
smokers living in households where smok­
ing occurs inside, home exposure is such a 
significant component of total SHS exposure 
that smokefree legislation cannot materially 
reduce their exposure. Similarly it appears 
that for those in lower socio  economic house­
holds, exposure in public and work settings 
must have been a smaller component of total 
exposure. Although there is a clear increase in 
the number of smokefree homes in England 
with the proportion of nonsmokers living in 
households that are largely smokefree increas­
ing over time from 87% in 1998 to 94% in 
2008, our findings underline the importance 
of finding further ways to reduce exposure 
among the most exposed groups, notably 
those exposed at home and those from lower­
SES groups and the importance of continuing 
to monitor exposure given that data presented Sims et al.
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in Figure 2 suggest that exposure in these 
groups may have leveled off postlegislation. 
Importantly, however, there was no signifi­
cant increase in exposure among any groups.
Conclusion
Smokefree legislation in England led to signifi­
cant reductions in population exposure to SHS. 
These reductions were additional to already 
declining exposures, which in turn, likely 
reflects the success of tobacco control poli­
cies implemented over the period examined. 
Although secular declines in exposure were 
seen among all population groups, the study 
was unable to detect significant reductions in 
exposure following the legislation in popu­
lation subgroups with the greatest exposure 
(those living in homes where smoking occurs 
inside on most days and those in lower­SES 
households). Although we were unable to for­
mally examine trends in inequalities due to the 
periods of missing data, our data suggest that 
absolute inequalities in exposure declined up to 
1 July 2007 (when measured using geometric 
mean cotinine), but subsequently increased 
after smokefree legislation was implemented, 
albeit affecting an ever smaller proportion of 
the population. This highlights the need both 
for further follow­up, requiring regular pop­
ulation­based cotinine surveillance data, and 
for further efforts to reduce SHS exposure to 
benefit those who remain most exposed.
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